Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1712.61 (Glytoucan)

Id:da700a4e-a4ba-5b1a-bfc4-8d6b7abf2902

Glytoucan:G54811KN

Results found

Linked to

	Label	Description
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G15204IM-GLYCOSEQ00099706 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000063 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G62349ZP-GLYCOSEQ00079759 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has motif I antigen Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G75564FK-GLYCOSEQ00125314 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G99663DA-GLYCOSEQ00002071 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G94297FY-GLYCOSEQ00076463 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G16201LW-GLYCOSEQ00115951 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G54322HH-GLYCOSEQ00012714 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G15204IM-GLYCOSEQ00099706 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000063 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G62349ZP-GLYCOSEQ00079759 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has motif I antigen

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G75564FK-GLYCOSEQ00125314 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G99663DA-GLYCOSEQ00002071 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G94297FY-GLYCOSEQ00076463 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G16201LW-GLYCOSEQ00115951 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1712.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G54322HH-GLYCOSEQ00012714 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.